Nurses are essential to optimal patient outcomes. Please join the International Myeloma Foundation’s Nurse Leadership Board for a case-based presentation of nursing implications of the evolving treatment paradigms in patients with multiple myeloma. The nurse’s roles as patient manager, advocate, and educator are integrated into this engaging 1.5 CNE learning opportunity. The nursing implications of recently approved and upcoming myeloma therapies as well as the latest myeloma diagnostic criteria and testing will be discussed.
Sponsored by the International Myeloma Foundation. This activity issupported by an educational grant from Bristol-Myers Squibb, Celgene Corporation, Onyx Pharmaceuticals, and Takeda Oncology.
